Hot Stock Alerts

Potential Breakout Stocks of the Day:

Best Stocks in 2015 - VLTC EGRX ANTH
Best Penny Stocks in 2015 - AXN NYMX
Today's Biggest Gainers - Hot Stocks - SHAK
Top Stocks 2015 - TWTR AMZN SPXL
Top Penny Stocks 2015 - ISR SD DPW
Shale Stocks -

Receive My Best Current Trading Ideas - Premium Room

Stock Market Closing Report - 11/25/15 - November 25, 2015

Tuesday, September 8, 2009

Opexa Therapeutics OPXA Positive Tovaxin Data

September 8, 2009 - Shares of Opexa Therapeutics, Inc. (OPXA) are surging in pre market as the company released positive trial data this morning. OPXA stock is trading at $2.72 Up 78%.

Opexa Reports Additional Favorable Data with Tovaxin® for Multiple Sclerosis

Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced results from further analysis of the double-blind, placebo-controlled, 52-week Phase IIb TERMS clinical study of 150 patients with Relapsing Remitting MS (RRMS). This analysis evaluated patients with an annualized relapse rate of one or greater at study entry (ARR≥1). More than 83% of the Tovaxin-treated group (n=85) remained relapse free at one year and the annualized relapse rate after treatment decreased to 0.20, a 42% reduction compared to placebo.

Full Article

For the latest updates on the stock market, visit, or Subscribe for Free